Flash. Hem. Erythropoietin-stimulating agents

What is a common cardiovascular side effect associated with erythropoietin-stimulating agents?

How might erythropoietin-stimulating agents affect the clotting system?

In some patients, what musculoskeletal side effect might ESAs induce?

Why should ESAs be used cautiously in patients with cancer?

Why is it crucial to monitor hemoglobin levels regularly in patients receiving ESAs?

For what group of patients is there a black box warning concerning the use of ESAs?

Before administering an ESA, what patient parameter should the nurse review?

How should a nurse educate a patient on the importance of following up on scheduled lab work while receiving ESAs?

What advice should a nurse provide to a patient receiving erythropoietin-stimulating agents concerning potential hypertension?

If a patient reports sudden shortness of breath, chest pain, or leg swelling while on ESAs, what action should be recommended?